Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D010064:Embryo Implantation / Q000187:drug effects; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D007774:Lactation / Q000187:drug effects; D008781:Methyltyrosines / Q000494:pharmacology; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012636:Secretory Rate / Q000187:drug effects
D004873:Ergolines; D008781:Methyltyrosines; D001971:Bromocriptine; D012110:Reserpine; D011388:Prolactin